Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Cancer care across the healthcare continuum has been revolutionized by advances in the understanding and application of genomics. The paradigm shift to biomarker-driven treatment decisions is a large step toward achieving precision oncology, which is the use of tumor-specific information, like genomic information, to inform cancer care.
A person with cancer will need vascular access of some type if they will be receiving IV treatment.
The ONS Oncology Nurse Orientation Program, provides didactic content for nurses new to oncology. The course is evidence-based, incorporates ONS standards and guidelines, and supports new oncology nurses working toward certification based on the ONS Oncology Nurse Generalist Competencies.
Learn about the process, risks, monitoring needs, and potential side effects of CAR T-cell therapy treatment of hematologic malignancies, with an emphasis on patient and family education. An interactive scenario and supporting resources reinforce learning.
IV infusion remains a primary means of administering antineoplastic therapy. The presence of an IV access device and the administration of certain types of medication can result in complications. This course reviews risk factors, manifestations of complications, and prevention strategies for vascular access devices.
Late or delayed effects are complications caused by cancer treatment that arise months or years after treatment ends. This huddle card highlights the treatment modalities linked to the risk of late effects and provides nursing considerations.